Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-15, Stock:JNJ, The news for the past five days is as follows:
2018-10-08: NEWS1: Johnson & Johnson Offers an Attractive Investment Proposition.NEWS2: Notable Monday Option Activity: AKCA, ACN, JNJ.NEWS3: Notable Monday Option Activity: AKCA, ACN, JNJ.NEWS4: Are These Beaten-Down Clinical-Stage Biotech Stocks Buys?.NEWS5: Are These Beaten-Down Clinical-Stage Biotech Stocks Buys?.NEWS6: Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick.NEWS7: Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick.NEWS8: Johnson & Johnson Vision Launches Worldwide Campaign to #SpotlightSight in Honor of World Sight Day.NEWS9: Are These Beaten-Down Clinical-Stage Biotech Stocks Buys?.NEWS10: Geron Stock: Buy, Sell, or Hold?.NEWS11: Geron Stock: Buy, Sell, or Hold?.NEWS12: JNJ’s $3.7 Billion Deal for Hepatitis B Gene Silencing Drug.NEWS13: Geron Stock: Buy, Sell, or Hold?.NEWS14: Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip?.NEWS15: Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip?.NEWS16: How Is Arrowhead Pharmaceuticals Stock Positioned?.NEWS17: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS18: Is Arrowhead Pharmaceuticals, Inc. a Buy on the Dip?.NEWS19: 8 Stocks to Buy That Will Never Go Out of Style.NEWS20: 8 Stocks to Buy That Will Never Go Out of Style.
2018-10-09: NEWS1: 4 Reasons to Be Wary of This Animal Health IPO.NEWS2: Why Arbutus Biopharma Stock Plunged 24.4% Today.NEWS3: 10 S&P 500 Stocks to Buy for the Long Term.NEWS4: ARWR Stock Sinks After Signing a Big Collaboration Deal.NEWS5: ARWR Stock Sinks After Signing a Big Collaboration Deal.NEWS6: How Artificial Intelligence Is Helping Pharmaceuticals Develop Drugs.NEWS7: How Artificial Intelligence Is Helping Pharmaceuticals Develop Drugs.NEWS8: Johnson & Johnson (JNJ) Q3 Earnings Preview: Here's What to Look Out For.NEWS9: Johnson & Johnson (JNJ) Q3 Earnings Preview: Here's What to Look Out For.NEWS10: Notable ETF Inflow Detected - QUAL, JNJ, V, XOM.NEWS11: Notable ETF Inflow Detected - QUAL, JNJ, V, XOM.NEWS12: Orchestra BioMed™ Adds Three Industry Leaders to Strategic Advisory Board.NEWS13: Here's Why Geron Plummeted 69% in September.NEWS14: Here's Why Geron Plummeted 69% in September.NEWS15: ARWR Stock Sinks After Signing a Big Collaboration Deal.NEWS16: Johnson & Johnson (JNJ) Q3 Earnings Preview: Here&apos;s What to Look Out For.NEWS17: Here&apos;s Why Geron Plummeted 69% in September.NEWS18: J&J's Stelara succeeds in chronic bowel disease study.NEWS19: Health Care Sector Update for 10/09/2018: AFMD, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS20: Health Care Sector Update for 10/09/2018: AFMD, ZIOP, JNJ, PFE, ABT, MRK, AMGN.NEWS21: An Overview of Johnson & Johnson’s Neuroscience Segment.
2018-10-10: NEWS1: Johnson & Johnson (JNJ) Stock Moves -1.06%: What You Should Know.NEWS2: Johnson & Johnson (JNJ) Stock Moves -1.06%: What You Should Know.NEWS3: Johnson & Johnson (JNJ) Stock Moves -1.06%: What You Should Know.NEWS4: 5 Healthcare Stocks to Buy for Complete Portfolio Wellness.NEWS5: 5 Healthcare Stocks to Buy for Complete Portfolio Wellness.NEWS6: Alexion Pharmaceuticals’ Operational Performance.NEWS7: Analyzing Alexion Pharmaceuticals’ Top-Line Trends.NEWS8: How Alexion Pharmaceuticals Is Positioned in October.NEWS9: Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates.NEWS10: Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates.NEWS11: J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS12: J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS13: 5 Healthcare Stocks to Buy for Complete Portfolio Wellness.NEWS14: J&J&apos;s Stelara Succeeds in Phase III Ulcerative Colitis Study.NEWS15: How Novartis’s Sandoz Business Has Been Performing Recently.NEWS16: Arbutus (ABUS) Plunges on Disappointing HBV Pipeline Updates.NEWS17: Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN.NEWS18: Health Care Sector Update for 10/10/2018: IGC, AKRX, JNJ, PFE, ABT, MRK, AMGN.NEWS19: How Intuitive’s Bottom Line Is Expected to Look in Q3 2018.NEWS20: Why Most Analysts Are Bullish on Intuitive Surgical in October.NEWS21: 10 S&P 500 Stocks to Buy for the Long-Term.NEWS22: 10 S&P 500 Stocks to Buy for the Long-Term.
2018-10-11: NEWS1: Here's Why Arrowhead Pharmaceuticals Skyrocketed Almost 30% in September.NEWS2: Here's Why Arrowhead Pharmaceuticals Skyrocketed Almost 30% in September.NEWS3: Here&apos;s Why Arrowhead Pharmaceuticals Skyrocketed Almost 30% in September.NEWS4: Jury clears J&J of liability in New Jersey talc cancer case.NEWS5: J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings.NEWS6: J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings.NEWS7: Abbott Laboratories Expected to Report Q3 Sales of $7.6 Billion.NEWS8: J&J (JNJ) to Set the Ball Rolling for Pharma Q3 Earnings.NEWS9: ABT Stock Fell ~3.3% on October 10 despite Analyst Upgrade.NEWS10: Health Care Sector Update for 10/11/2018: TRXC, SEM, BOLD, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 10/11/2018: TRXC, SEM, BOLD, JNJ, PFE, ABT, MRK, AMGN.NEWS12: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2018.NEWS13: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2018.NEWS14: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2018.NEWS15: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2018.NEWS16: How Could JNJ’s Pharmaceuticals Business Perform in Q3 2018?.NEWS17: How Analysts View Alexion Pharmaceuticals Stock in October.
2018-10-12: NEWS1: Cramer's game plan: Increased volatility could turn positive with help from Trump, Fed.NEWS2: Banks Provide Positive Start to Q3 Earnings Season.NEWS3: This 1 Stock Could Send the Entire Healthcare Sector Soaring -- or Plunging.NEWS4: This 1 Stock Could Send the Entire Healthcare Sector Soaring -- or Plunging.NEWS5: This 1 Stock Could Send the Entire Healthcare Sector Soaring -- or Plunging.NEWS6: J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion.NEWS7: J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion.NEWS8: Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal.NEWS9: Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal.NEWS10: Bargain Hunting Contributes To Higher Close On Wall Street - U.S. Commentary.NEWS11: Bargain Hunting Contributes To Higher Close On Wall Street - U.S. Commentary.NEWS12: Dow Movers: VZ, V.NEWS13: Dow Movers: VZ, V.NEWS14: What Vertex Pharmaceuticals’ Valuation Trend Indicates.NEWS15: Bristol-Myers Inks Deal and Invests $12 Million in Compugen.NEWS16: Bristol-Myers Inks Deal and Invests $12 Million in Compugen.NEWS17: Is a Surprise Coming for Johnson & Johnson (JNJ) This Earnings Season?.NEWS18: Is a Surprise Coming for Johnson & Johnson (JNJ) This Earnings Season?.NEWS19: Pharma Stock Roundup: ABBV, NVS&apos; Humira Biosimilar Agreement, BMY&apos;s New Cancer Deal.NEWS20: J&J (JNJ) Gets FDA Approval for Xarelto Label Expansion.NEWS21: 3 Big Pharma Stocks Racing Along the Road to China.NEWS22: 3 Big Pharma Stocks Racing Along the Road to China.NEWS23: Is a Surprise Coming for Johnson & Johnson (JNJ) This Earnings Season?.NEWS24: Dow 30 Stock Roundup: Walgreens&apos; Earnings Top, UTX Board OKs Dividend Hike.NEWS25: 3 Big Pharma Stocks Racing Along the Road to China.NEWS26: Jury clears J&J of liability in New Jersey talc cancer case.NEWS27: A Look at Abbott Laboratories’ Third-Quarter Earnings Estimates.NEWS28: Could JNJ’s Medical Device Business Report Strong Growth in Q3?.

Answer: Rise